The Senate Finance Committee (SFC) convened a hearing to consider the nomination of Dr. Mehmet Oz to serve as Administrator of the Centers for Medicare and Medicaid Services (CMS). Democrats largely focused on the potential impact of Medicaid cuts through reconciliation. Dr. Oz admitted that he is not familiar with the details of the proposal and avoided taking a stance on Medicaid aside… (McClurg, March 17, 2025) #Drug Pricing, #Health Information Technology, #Medicare Advantage, #Program Integrity, #Rural Health, #Telehealth

The Medicare Payment Advisory Commission (MedPAC) released its March 2025 Report to Congress. The first nine chapters review Medicare payment policy, payment adequacy indicators, and the Commission’s recommendations for updating 2026 payments across sectors of fee-for-service (FFS) Medicare. MedPAC recommends higher-than-current-law payment updates for acute care hospitals and physicians, and an update equal to current law for outpatient dialysis facilities…. (Testa, March 13, 2025) #Ambulatory Surgical Centers, #Cost-Sharing, #Costs, #Coverage Decisions, #Home Health, #Hospice, #Hospitals, #Inpatient Rehabilitation Facilities, #Medicare Advantage, #Medicare Part D, #Physicians, #Primary Care, #Quality, #Readmissions, #Risk Adjustment, #Skilled Nursing Facilities

The Medicaid and CHIP Payment and Access Commission (MACPAC) released its March 2025 Report to Congress, with (1) recommendations to improve the transparency and usability of external quality review findings in managed care oversight and accountability (2) using provisional plans of care in support of timely access to home and community-based services (HCBS); and (3) reducing administrative burden related to… (Marceno, March 13, 2025) #Coverage Decisions, #Home Health

The Senate Health, Education, Labor & Pensions (HELP) Committee voted to advance Dr. Martin Makary for Commissioner of the Food and Drug Administration (FDA) and Dr. Jayanta Bhattacharya to serve as Director of the National Institutes of Health (NIH) sending their nominations to the full Senate for confirmation. Dr. Makary was approved in a 14-9 vote, with Democratic Senators Maggie… (Eisen, March 13, 2025) #COVID-19, #Food and Drug Administration, #National Institutes of Health, #Women’s Health, #Workforce

The House Ways & Means (W&M) Health Subcommittee convened a hearing to examine challenges in post-acute care access, particularly focusing on Medicare Advantage (MA) plans, Medicaid funding, and nursing home staffing standards. Lawmakers from both parties raised concerns about MA plans’ prior authorization practices and their impact on patient care. Democrats emphasized the risks of proposed Medicaid cuts and the importance… (Eisen, March 12, 2025) #Medicare Advantage, #Rural Health

The Center for Medicare & Medicaid Innovation (CMMI) issued a statement announcing certain models will be canceled or end by December 31, 2025. The declaration was made after a review of the model portfolio by the Trump administration, which asserts that models must reduce spending in addition to maintaining or improving quality. The Biden administration sought to position improvements in quality… (Testa, March 12, 2025) #Care Coordination, #Costs, #Delivery Reform, #Demonstration Programs, #Generic Drugs, #Grants, #Primary Care, #Quality